代血浆及术中抢救用药。
结果输注代血浆和平衡液后全血粘度、血浆粘度、HCT、红细胞聚集指数、纤维蛋白原两组均较输注前明显降低（P<0.05），但两组间比较无显著差异（P>0.05）。
Results Blood viscosity, HCT, index of RBC aggregation and fibrinogen decreased significantly(P<0.05)in each group and there was no significant difference between the two groups(P>0.05).
目的：建立加兰他敏血浆药物浓度的HPLC - UV检测法，研究其在人体的药代动力学和相对生物利用度。
OBJECTIVE: to develop a HPLC-UV method to determine the concentration of galanthamine in human plasma and study its pharmacokinetic profiles and bioequivalence.
多项研究表明，4 -氧代二氢喹啉类有良好的口服利用率及中等程度的血浆清除率，不仅对核苷酸聚合酶产生抑制，还可以抑制细胞内的病毒复制。
Many studies show that 4-oxo-dihydroquinolines have good oral bioavailability and plasma clearance, and they suppress both the DNA polymerase of HSV and virus replication in the cells.
目的：建立SPE—HPLC法测定人血浆中喹那普利及其代谢产物喹那普利拉的浓度，以研究喹那普利及喹那普利拉在健康志愿者中的药代动力学和相对生物利用度。
Objective:To establish a SPE-HPLC method for the determination of quinapril and its active metabolite quinaprilat in human plasma and to evaluate their pharmacokinetics and relative bioavailability.
目的：建立高效液相色谱-电化学检测法测定大鼠血浆中灯盏乙素浓度方法并研究其药代动力学。
Aim: to develop a high performance liquid chromatographic (HPLC) with electrochemical detection method for the determination of scutellarin in rat plasma and to study its pharmacokinetics in rats.
过去12年来的临床和药代动力学研究显示了口服后血浆和组织内抗坏血酸的浓度是被严格控制的。
Clinical and pharmacokinetic studies conducted in the past 12 years showed that oral ascorbate levels in plasma and tissue are tightly controlled.
目的：研究强的松、强的松龙在10名男性健康志愿者血浆及血中有核细胞内的可逆代谢药代动力学。
OBJECTIVE: To investigate reversible metabolic pharmacokinetics of prednisone and prednisolone in plasma and blood nucleated cells in 10 healthy male volunteers.
目的研究亚胺培南在严重烧伤早期痂下组织液和血浆中的药代动力学变化。
Objective To study the change of pharmacokinetics parameters of imipenem in the interstitial fluids under eschar of burn rabbits in the early stage.
方法：采用LC/MS/MS（APCI源）测定地洛他定的血浆浓度，并计算药代动力学参数。
METHODS: The concentrations of desloratadine were determined by LC/MS/MS with APCI and the pharmacokinetic parameters were calculated.
方法：采用LC/MS/MS（APCI源）测定地洛他定的血浆浓度，并计算药代动力学参数。
METHODS: The concentrations of desloratadine were determined by LC/MS/MS with APCI and the pharmacokinetic parameters were calculated.
应用推荐